Adaptive Biotechnologies Statistics
Total Valuation
MUN:1HM has a market cap or net worth of EUR 2.47 billion. The enterprise value is 2.47 billion.
| Market Cap | 2.47B |
| Enterprise Value | 2.47B |
Important Dates
The next estimated earnings date is Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 152.67M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.70% |
| Shares Change (QoQ) | +7.29% |
| Owned by Insiders (%) | 3.15% |
| Owned by Institutions (%) | 78.96% |
| Float | 117.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.47 |
| PB Ratio | 14.19 |
| P/TBV Ratio | 34.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -36.37 |
| EV / Sales | 11.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -46.01 |
Financial Position
The company has a current ratio of 3.38, with a Debt / Equity ratio of 1.05.
| Current Ratio | 3.38 |
| Quick Ratio | 3.11 |
| Debt / Equity | 1.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.39 |
| Interest Coverage | -6.64 |
Financial Efficiency
Return on equity (ROE) is -37.21% and return on invested capital (ROIC) is -11.29%.
| Return on Equity (ROE) | -37.21% |
| Return on Assets (ROA) | -9.32% |
| Return on Invested Capital (ROIC) | -11.29% |
| Return on Capital Employed (ROCE) | -19.20% |
| Revenue Per Employee | 348,017 |
| Profits Per Employee | -109,618 |
| Employee Count | 619 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 8.06 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +228.38% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +228.38% |
| 50-Day Moving Average | 16.44 |
| 200-Day Moving Average | 35.24 |
| Relative Strength Index (RSI) | 58.64 |
| Average Volume (20 Days) | 167 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.69 |
Income Statement
In the last 12 months, MUN:1HM had revenue of EUR 215.42 million and -67.85 million in losses. Loss per share was -0.45.
| Revenue | 215.42M |
| Gross Profit | 140.20M |
| Operating Income | -66.64M |
| Pretax Income | -67.84M |
| Net Income | -67.85M |
| EBITDA | -51.22M |
| EBIT | -66.64M |
| Loss Per Share | -0.45 |
Balance Sheet
The company has 181.34 million in cash and 182.09 million in debt, giving a net cash position of 2.70 million.
| Cash & Cash Equivalents | 181.34M |
| Total Debt | 182.09M |
| Net Cash | 2.70M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 174.08M |
| Book Value Per Share | 1.14 |
| Working Capital | 168.82M |
Cash Flow
In the last 12 months, operating cash flow was -51.59 million and capital expenditures -2.05 million, giving a free cash flow of -53.64 million.
| Operating Cash Flow | -51.59M |
| Capital Expenditures | -2.05M |
| Free Cash Flow | -53.64M |
| FCF Per Share | n/a |
Margins
Gross margin is 65.08%, with operating and profit margins of -30.93% and -31.50%.
| Gross Margin | 65.08% |
| Operating Margin | -30.93% |
| Pretax Margin | -31.49% |
| Profit Margin | -31.50% |
| EBITDA Margin | -23.78% |
| EBIT Margin | -30.93% |
| FCF Margin | n/a |
Dividends & Yields
MUN:1HM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.70% |
| Shareholder Yield | -2.70% |
| Earnings Yield | -2.75% |
| FCF Yield | -2.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MUN:1HM has an Altman Z-Score of -0.66 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.66 |
| Piotroski F-Score | 3 |